Basic Information
| LncRNA/CircRNA Name | GIHCG |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | tongue squamous cell carcinoma |
| ICD-0-3 | C02 |
| Methods | qPCR |
| Sample | TSCC tissues, cell lines (SCC4, SCC1, UM1, Cal27, NHOK) |
| Expression Pattern | up-regulated |
| Function Description | we indicated that high GIHCG expression was positively associated with poor overall survival. Elevated expression of GIHCG inhibited the miR-429 expression in TSCC cells. |
| Pubmed ID | 29953645 |
| Year | 2018 |
| Title | Long noncoding RNA GIHCG enhanced tongue squamous cell carcinoma progression through regulating miR-429. |
External Links
| Links for GIHCG | GenBank HGNC NONCODE |
| Links for tongue squamous cell carcinoma | OMIM COSMIC |